Behavior
Conduct extensive pain, sensory, motor, and cognitive behavioral testing.
MD Biosciences is dedicated to advancing the study of pain and neurodegenerative diseases. Understanding pain and novel mechanisms requires deep scientific knowledge as well as the expertise and infrastructure to effectively evaluate therapeutic candidates in early and translational phases. As with any model, selecting the right species, stimuli, assessments, and endpoints is critical to conducting quality studies that provide meaningful insight into the condition and potential therapies. MD Biosciences’ expertise in study design ensures the generation of predictive data from preclinical research.
MD Biosciences offers comprehensive in vivo measures and endpoint assessments, delivering robust data packages to support critical research decisions in the evolving landscape of drug development and biomedical research.
Conduct extensive pain, sensory, motor, and cognitive behavioral testing.
Explore inflammatory and pain biomarkers from disease-specific tissues.
Analyze tissue and cellular changes in disease, pain, and neurodegeneration.
Measure motor and sensory evoked potentials to assess disease progression and pain.
Measuring pain is often times straight forward using stimuli and measuring the resulting response. But the clinical situation not only evaluates response to the stimuli but the emotional component that patients report. In animal studies, we must rely on vocalization assessments and tests such as the open field to see how animals exhibit anxiety and behave emotionally as a result of the painful condition.